Dalazatide TFA
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-P3507A-1MG | 1 mg | 722,00 | Add | |
| HY-P3507A-5MG | 5 mg | 1'949,00 | Add | |
| HY-P3507A-10MG | 10 mg | 3'240,00 | Add |
* CHF, excl. 7.7% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
ShK-186 TFA
Dalazatide (ShK-186) TFA is a specific Kv1.3 potassium channel peptide inhibitor. Dalazatide TFA can be used in the study of autoimmune diseases such as multiple sclerosis (MS), lupus erythematosus, psoriasis, rheumatoid arthritis, type 1 diabetes and inflammatory bowel disease.
| Category | Peptide |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Metabolic Disease, Inflammation/Immunology, Membrane Transporter/Ion Channel |
| Grade | Clinical information: No Development Reported |
| Purity | 98.44% |
| Storage Conditions | Sealed storage, away from moisture; Powder -80°C 2 years, -20°C 1 year; In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room temperature |
| Material Safety Data Sheet | Download PDF |
